SUPERLUMINAL MEDICINES
Live / Allowed — Notice of allowance issued (as of 21 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99365859
- Mark type
- Design + words
- Filed
- 29 Aug 2025
- Published for opposition
- 24 Feb 2026
- Attorney of record
- Gregory B. Coy
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical agents modulating high value protein targets such as G protein coupled receptors
- Class 042 — Scientific and technological services: development of pharmaceutical preparations and medicines
Owner
- Superluminal Medicines, Inc., Boston, MA, US
- Superluminal Medicines, Inc., Boston, MA, US
Prosecution history
- 02 Sept 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Sept 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Sept 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
- 21 Apr 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Feb 2026 — PUBLISHED FOR OPPOSITION
- 18 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jan 2026 — EXAMINER'S AMENDMENT ENTERED
- 29 Jan 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 29 Jan 2026 — EXAMINERS AMENDMENT E-MAILED